trial

Cognitive Remediation in 22q11DS

NCTId NCT01781923
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 38 (actual)
Sponsored by Duke University
Primary completion 2015-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
38 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2010-10
Primary completion
2015-06
Eligibility
ALL · 11 Years · 17 Years

Interventions & indications

Drugs
Cognitive remediation programSmall group social skills training

Sponsors

Duke UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
Harvard UniversityCollaborator
University of Pittsburgh Medical CenterCollaborator

Investigators

1
Vandana Shashi, MDPrincipal Investigator

Sites

1 total
Durham, United States

Facts & assertions

4 sourced
Enrollment
38
Phase
NA
Primary Completion Date
2015-06
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive remediation program
drug
Small group social skills training
drug
lead_sponsor
Duke University
company
collaborator
National Institute of Mental Health (NIMH)
company
Harvard University
company
indication
22q11.2 Deletion Syndrome
indication
DiGeorge Syndrome
indication
Velo-cardio-facial Syndrome
indication
investigator
Vandana Shashi, MD
person